253 related articles for article (PubMed ID: 30793414)
1. Patients' Global Impression of Change in the management of peripheral neuropathic pain: Clinical relevance and correlations in daily practice.
Perrot S; Lantéri-Minet M
Eur J Pain; 2019 Jul; 23(6):1117-1128. PubMed ID: 30793414
[TBL] [Abstract][Full Text] [Related]
2. Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study.
Mankowski C; Poole CD; Ernault E; Thomas R; Berni E; Currie CJ; Treadwell C; Calvo JI; Plastira C; Zafeiropoulou E; Odeyemi I
BMC Neurol; 2017 Apr; 17(1):80. PubMed ID: 28431564
[TBL] [Abstract][Full Text] [Related]
3. Relationship between pain relief, reduction in pain-associated sleep interference, and overall impression of improvement in patients with postherpetic neuralgia treated with extended-release gabapentin.
Mehta N; Bucior I; Bujanover S; Shah R; Gulati A
Health Qual Life Outcomes; 2016 Apr; 14():54. PubMed ID: 27037091
[TBL] [Abstract][Full Text] [Related]
4. Relationships Among Pain Quality, Pain Impact, and Overall Improvement in Patients with Postherpetic Neuralgia Treated with Gastroretentive Gabapentin.
Freeman R; Wallace MS; Sweeney M; Backonja MM
Pain Med; 2015 Oct; 16(10):2000-11. PubMed ID: 26115203
[TBL] [Abstract][Full Text] [Related]
5. Pain-relieving effectiveness, quality of life and tolerability of repeated capsaicin 8% patch treatment of peripheral neuropathic pain in Scandinavian clinical practice.
Hansson P; Jensen TS; Kvarstein G; Strömberg M
Eur J Pain; 2018 May; 22(5):941-950. PubMed ID: 29388284
[TBL] [Abstract][Full Text] [Related]
6. Treatment Impact on Patient-Reported Outcomes in Peripheral Neuropathic Pain: Comparing Single Intervention With Topical High-Concentration Capsaicin to Daily Oral Pregabalin.
Viel E; Eerdekens M; Kandaswamy P
Pain Physician; 2021 Sep; 24(6):453-463. PubMed ID: 34554688
[TBL] [Abstract][Full Text] [Related]
7. QAPSA: post-marketing surveillance of capsaicin 8% patch for long-term use in patients with peripheral neuropathic pain in France.
Lantéri-Minet M; Perrot S
Curr Med Res Opin; 2019 Mar; 35(3):417-426. PubMed ID: 30550354
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of pregabalin using a flexible, optimized dose schedule in Korean patients with peripheral neuropathic pain: a 10-week, randomized, double-blind, placebo-controlled, multicenter study.
Moon DE; Lee DI; Lee SC; Song SO; Yoon DM; Yoon MH; Kim HK; Lee YW; Kim C; Lee PB
Clin Ther; 2010 Dec; 32(14):2370-85. PubMed ID: 21353106
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Postherpetic Neuralgia With Gastroretentive Gabapentin: Interaction of Patient Demographics, Disease Characteristics, and Efficacy Outcomes.
Kantor D; Panchal S; Patel V; Bucior I; Rauck R
J Pain; 2015 Dec; 16(12):1300-1311. PubMed ID: 26409117
[TBL] [Abstract][Full Text] [Related]
10. Prospective, non-interventional study on the tolerability and analgesic effectiveness over 12 weeks after a single application of capsaicin 8% cutaneous patch in 1044 patients with peripheral neuropathic pain: first results of the QUEPP study.
Maihofner C; Heskamp ML
Curr Med Res Opin; 2013 Jun; 29(6):673-83. PubMed ID: 23551064
[TBL] [Abstract][Full Text] [Related]
11. The Role of Qutenza® (Topical Capsaicin 8%) in Treating Neuropathic Pain from Critical Ischemia in Patients with End-Stage Renal Disease: An Observational Cohort Study.
Aitken E; McColl G; Kingsmore D
Pain Med; 2017 Feb; 18(2):330-340. PubMed ID: 28204726
[TBL] [Abstract][Full Text] [Related]
12. Brief pain inventory--facial minimum clinically important difference.
Sandhu SK; Halpern CH; Vakhshori V; Mirsaeedi-Farahani K; Farrar JT; Lee JY
J Neurosurg; 2015 Jan; 122(1):180-90. PubMed ID: 25361481
[TBL] [Abstract][Full Text] [Related]
13. Topical capsaicin (high concentration) for chronic neuropathic pain in adults.
Derry S; Sven-Rice A; Cole P; Tan T; Moore RA
Cochrane Database Syst Rev; 2013 Feb; (2):CD007393. PubMed ID: 23450576
[TBL] [Abstract][Full Text] [Related]
14. Progressive Response to Repeat Application of Capsaicin 179 mg (8% w/w) Cutaneous Patch in Peripheral Neuropathic Pain: Comprehensive New Analysis and Clinical Implications.
Freynhagen R; Argoff C; Eerdekens M; Engelen S; Perrot S
Pain Med; 2021 Oct; 22(10):2324-2336. PubMed ID: 33871648
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy or postherpetic neuralgia: Open-label, non-comparative, flexible-dose study.
Baron R; Brunnmüller U; Brasser M; May M; Binder A
Eur J Pain; 2008 Oct; 12(7):850-8. PubMed ID: 18242109
[TBL] [Abstract][Full Text] [Related]
16. Treatment of peripheral neuropathic pain by topical capsaicin: Impact of pre-existing pain in the QUEPP-study.
Maihöfner CG; Heskamp ML
Eur J Pain; 2014 May; 18(5):671-9. PubMed ID: 24259265
[TBL] [Abstract][Full Text] [Related]
17. High-concentration topical capsaicin in the management of refractory neuropathic pain in patients with neurofibromatosis type 1: a case series.
Bardo-Brouard P; Luizard C; Valeyrie-Allanore L; Goujon C; Do B; Colin A; Wolkenstein P; Paul M
Curr Med Res Opin; 2018 May; 34(5):887-891. PubMed ID: 29368950
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and Safety of 0.625% and 1.25% Capsaicin Patch in Peripheral Neuropathic Pain: Multi-Center, Randomized, and Semi-Double Blind Controlled Study.
Moon JY; Lee PB; Kim YC; Lee SC; Nahm FS; Choi E
Pain Physician; 2017 Feb; 20(2):27-35. PubMed ID: 28158151
[TBL] [Abstract][Full Text] [Related]
19. NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: results of a 52-week open-label study.
Simpson DM; Brown S; Tobias JK; Vanhove GF;
Clin J Pain; 2014 Feb; 30(2):134-42. PubMed ID: 23446088
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of pregabalin for peripheral neuropathic pain: results of an 8-week, flexible-dose, double-blind, placebo-controlled study conducted in China.
Guan Y; Ding X; Cheng Y; Fan D; Tan L; Wang Y; Zhao Z; Hong Z; Zhou D; Pan X; Chen S; Martin A; Tang H; Cui L
Clin Ther; 2011 Feb; 33(2):159-66. PubMed ID: 21444113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
